Status:
COMPLETED
REM (Risk Of Endometrial Malignancy)
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Endometrial Disease
Eligibility:
FEMALE
45-80 years
Phase:
NA
Brief Summary
The purpose of this study was to obtain a predictive model to asses the Risk of Endometrial Malignancy (REM) in women with ultrasound endometrial abnormalities.
Detailed Description
Objective: It is often difficult to distinguish a benign endometrial disease from a malignancy and tools to help physician are needed, in order to triage patients into high and low risk of endometrial...
Eligibility Criteria
Inclusion
- aged between 45 and 80 years;
- Eastern Cooperative Oncology Group performance status 0-2 according to World Health Organization (WHO) criteria;
- informed consent obtained from the patients.
Exclusion
- abnormal cardiac, haematological, renal, respiratory and/or hepatic functions;
- presence of a previous malignancy;
- presence of concomitant adnexal masses.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
741 Patients enrolled
Trial Details
Trial ID
NCT01830192
Start Date
January 1 2010
End Date
December 1 2012
Last Update
April 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
campus bio-medico of Rome
Rome, Italy, 00128